MOUNTAIN VIEW, Calif.--Pharsight, a clinical drug development software provider and consultancy here, has formed two partnerships: one with AstraZeneca R&D Molndal, of Sweden, and a broader one with Quintiles Transnational, a Research Triangle Park, NC-based provider of product development and commercialization services to the pharmaceutical industry.
The goal of the AstraZeneca alliance is to jointly deploy Pharsight's trial design software and methodologies for drug development to AstraZeneca's clinical development processes in a specific therapeutic area.
The Quintiles deal is part of a larger Pharsight partnership among organizations offering clinical development and scientific services.